Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
2.080
+0.010 (0.48%)
At close: Dec 26, 2025, 4:00 PM EST
2.080
0.00 (-0.01%)
After-hours: Dec 26, 2025, 7:51 PM EST
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $211.29 million as of December 26, 2025. Its market cap has increased by 68.33% in one year.
Market Cap
211.29M
Enterprise Value
185.91M
1-Year Change
68.33%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $211.29M, a decrease of -41.87%. That is a compound annual growth rate of -7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 211.29M | 35.16% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | 199.81M | -49.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |